Bhaven N. Sampat
I am a Professor at the Department of Health Policy and Management at Columbia University and a Research Associate at the National Bureau of Economic Research (NBER).
My research focuses on the economics and political economy of science and technology, primarily in the life sciences. My current projects examine:
- The effects of the globalization of drug patent protection on innovation, prices, and access to medicines
- The impact of the World War II research effort on the rate and direction of postwar science and innovation, and on the scientists involved
- The role of the government in pharmaceutical innovation, and implications for public policy
- How crises shape innovation and innovation policy
My previous work includes research on the political economy of the the NIH, the economic impact of public science, patent data as economic indicators, the law and economics of the patent system, pharmaceutical and life science patent policy, and university-industry technology transfer, among other topics.
You can find my CV here and my Google Scholar Profile here.
Recent research and writing
Sampat, Bhaven N. and Ken Shadlen. "The Covid-19 Innovation System" Health Affairs (2021)
Sampat, Bhaven N. "Whose Drugs Are These?" Issues in Science and Technology 36.4 (2020)
Margaret Kyle, Ken Shadlen, and Bhaven N. Sampat. "TRIPS, Patents, and Drug Prices in India" (2020) (email for copy)
Teaching
2020-2021
- Vaccine Innovation and Public Policy
- The Economics of Biomedical Research
- Innovations in Health Policy
- The Economics of Precision Medicine
Earlier
- Science, Evidence, and Politics in Health Policy (with Ronald Bayer)
- Integration of Science and Practice
- Program Evaluation
- Research Methods I/II
- Economics of Innovation (doctoral seminar, at ASU)
- Science, Technology, and Sustainable Development (doctoral seminar, at SIPA)
- Health and Development (at SIPA)
- U.S. Science and Technology Policy (at SIPA)
Professional Activities
- Columbia University Senate (2019-2021)
- Steering Committee, NBER Innovation Information Initiative
- Steering Committee, Columbia Precision Medicine and Society Initiative
- Advisory Editor, Research Policy
- Editorial Advisory Board, Milbank Quarterly